Aberrant ALK Tyrosine Kinase Signaling
- 1 August 2000
- journal article
- editorial
- Published by Elsevier in The American Journal of Pathology
- Vol. 157 (2) , 341-345
- https://doi.org/10.1016/s0002-9440(10)64545-2
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- ATIC-ALK: A Novel Variant ALK Gene Fusion in Anaplastic Large Cell Lymphoma Resulting from the Recurrent Cryptic Chromosomal Inversion, inv(2)(p23q35)The American Journal of Pathology, 2000
- Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemiaJournal of Clinical Investigation, 2000
- Chromosomal breakpoint positions suggest a direct role for radiation in inducing illegitimate recombination between the ELE1 and RET genes in radiation-induced thyroid carcinomasOncogene, 1999
- HMGI(Y) and HMGI-C DysregulationAdvances in Anatomic Pathology, 1999
- ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural receptor tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK)Oncogene, 1997
- Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous systemOncogene, 1997
- An Mll–AF9 Fusion Gene Made by Homologous Recombination Causes Acute Leukemia in Chimeric Mice: A Method to Create Fusion OncogenesCell, 1996
- Inhibition of FGF-stimulated phosphatidylinositol hydrolysis and neurite outgrowth by a cell-membrane permeable phosphopeptidePublished by Elsevier ,1996
- Fusion of the FUS gene with ERG in acute myeloid leukemia with t(16;21)(p11;q22)Genes, Chromosomes and Cancer, 1994
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994